Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

AXYX

Axonyx (AXYX)

Axonyx
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AXYX
일자시간출처헤드라인심볼기업
2006/09/2905:15Business WireAxonyx Stockholders Approve Merger with TorreyPines Therapeutics Inc.NASDAQ:AXYXAxonyx
2006/09/2200:00PR Newswire (US)TorreyPines Therapeutics to Present at the UBS Global Life Sciences ConferenceNASDAQ:AXYXAxonyx
2006/08/3100:00PR Newswire (US)TorreyPines Therapeutics to Present at the Thomas Weisel Partners 2006 Healthcare ConferenceNASDAQ:AXYXAxonyx
2006/08/0821:30Business WireAXONYX Inc. Announces Second Quarter 2006 Financial ResultsNASDAQ:AXYXAxonyx
2006/08/0722:30PR Newswire (US)TorreyPines Therapeutics Initiates Phase I Clinical Trial of NGX426, a Novel Oral Therapy for Migraine and Neuropathic PainNASDAQ:AXYXAxonyx
2006/08/0505:30Business WireAxonyx Receives Notice Related to Nasdaq Minimum Bid Price RuleNASDAQ:AXYXAxonyx
2006/07/2422:30PR Newswire (US)TorreyPines Therapeutics Completes Second Phase I Study for NGX267, a Selective M1 Agonist for the Treatment of Alzheimer's DisNASDAQ:AXYXAxonyx
2006/06/2100:00PR Newswire (US)TorreyPines Therapeutics to Present at the Jefferies & Company Life Sciences ConferenceNASDAQ:AXYXAxonyx
2006/06/1000:34PR Newswire (US)TorreyPines Therapeutics to Present at the 2006 Pacific Growth Equities Life Sciences Growth ConferenceNASDAQ:AXYXAxonyx
2006/06/0821:00Business WireAxonyx and TorreyPines to Host Webcast and Conference Call on Announced MergerNASDAQ:AXYXAxonyx
2006/06/0819:30Business WireAxonyx and TorreyPines Therapeutics Announce Merger Agreement; Transaction Creates Robust Portfolio in the CNS Disease AreaNASDAQ:AXYXAxonyx
2006/05/1605:15Business WireAxonyx Announces Completion of the Multiple-Dose Phase I Study of Posiphen(TM)NASDAQ:AXYXAxonyx
2006/05/1106:30Business WireAxonyx Inc. Reports First Quarter 2006 Financial ResultsNASDAQ:AXYXAxonyx
2006/05/0922:28Business WireAxonyx to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference; Presentation to be Web Cast Live on CorporatNASDAQ:AXYXAxonyx
2006/04/2421:30Business WireResearcher Reports Data on Effects of Posiphen(TM) on Human Neuronal Stem Cells; Posiphen May Support Stem Cell TransplantationNASDAQ:AXYXAxonyx
2006/04/2105:30Business WireAxonyx Reports Data on Effects of Phenserine on the Brains of Alzheimer's Disease Patients; PET Scans Show Increased Brain NeurNASDAQ:AXYXAxonyx
2006/04/2005:30Business WireAxonyx Reports Data on Stabilized Brain Volumes in Alzheimer's Disease Patients Treated with Phenserine; Analysis of Brain ScanNASDAQ:AXYXAxonyx
2006/03/1706:15Business WireAxonyx Reports Fourth Quarter and Full Year 2005 Financial ResultsNASDAQ:AXYXAxonyx
2006/03/0906:24Business WireAxonyx Regains Compliance with Nasdaq Minimum Bid Price RuleNASDAQ:AXYXAxonyx
2006/02/2322:33Business WireAxonyx to Present at the Wall Street Analyst Forum; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
2006/02/1422:33Business WireAxonyx Reports Phenserine Associated with Significant Amyloid Reduction in Phase I Trial; Results Support Dual Mechanisms of ActNASDAQ:AXYXAxonyx
2006/02/0723:00Business WireAxonyx to Present at BIO CEO & Investor Conference 2006; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
2006/01/3122:30Business WireAxonyx Announces Acceptance of Four Abstracts Highlighting Phenserine and Posiphen by the 9th International Geneva/Springfield SNASDAQ:AXYXAxonyx
2006/01/2422:30Business WireAxonyx Completes First Phase I Trial with Posiphen for Alzheimer's Disease ProgressionNASDAQ:AXYXAxonyx
2006/01/0422:30Business WireAxonyx Announces License of Phenserine to Daewoong Pharmaceutical Company for South KoreaNASDAQ:AXYXAxonyx
2005/11/0922:30Business WireAxonyx Inc. Announces Third Quarter Financial ResultsNASDAQ:AXYXAxonyx
2005/11/0806:47Business WireAxonyx Provides Update on Clinical Development Program and Strategic InitiativesNASDAQ:AXYXAxonyx
2005/10/2621:00Business WireAxonyx to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference; Presentation to Be Web Cast Live on Corporate WNASDAQ:AXYXAxonyx
2005/09/2022:00Business WireAxonyx Announces Results of Curtailed Phase III Clinical Trials for Phenserine in Alzheimer's DiseaseNASDAQ:AXYXAxonyx
2005/09/1521:30Business WireAxonyx to Present at the UBS 2005 Global Life Sciences Conference; Presentation to be Web Cast Live on Corporate Web SiteNASDAQ:AXYXAxonyx
 검색 관련기사 보기:NASDAQ:AXYX